Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

President Obama Receives Warm Welcome From AMA Physicians
The American Medical Association warmly welcomed U.S. President Barack Obama to its 158th annual meeting in Chicago. Like the president, the AMA is committed to health reform this year that provides all Americans with affordable, high-quality health coverage.

Pfizer's Sutent Is Recommended For Reimbursement For Gastrointestinal Stromal Tumor Patients By British Health Agency
Pfizer Inc said that the United Kingdom"s National Institute for Health and Clinical Excellence (NICE) has issued its final appraisal document (FAD) recommending reimbursement for Sutent (sunitinib malate) as a second-line treatment for patients with advanced gastrointestinal stromal tumor (GIST). This recommendation follows NICE"s recently published guidance recommending reimbursement for Sutent for the first-line treatment of advanced kidney cancer.
News of the day
Thousands Of Older People Dying Prematurely From Cancer, Say Researchers
As many as 15,000 people over 75 could be dying prematurely from cancer each year in the UK, according to research presented today at the National Cancer Intelligience Network (NCIN) conference.
Medical Devices

Science Magazine Spotlights 20 Years Of CF Research

An article in Science magazine this month highlights several promising new CF therapies, including VX-770 and VX-809 developed by Vertex Pharmaceuticals, as part of a look back at key moments in CF research since the discovery of the CF gene 20 years ago. The article notes the CF Foundation"s role in scientific discoveries: "The CF Foundation had been instrumental in funding the gene hunt and subsequent CF research, raising and investing tens of millions of dollars." In the piece, Francis Collins, former director of the National Human Genome Research Institute and co-discoverer of the CF gene, says the research community was initially skeptical about the Foundation"s focus on funding drug research to find a cure: "A lot of people thought that [CFF president] Bob Beall was going far out on a limb to put a lot of money into a strategy that was clearly risky." But now, following the Foundation"s investment of more than $75 million to develop VX-770 and VX-809, the "ò€¦two Vertex drugs are taking the CF world by storm." Cystic Fibrosis Foundation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009